Evidence map›Paper›PMID 35171035›Full record

ArticleMicrobiology spectrum2022

Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil.

Priscila Lamb Wink, Rafaela Ramalho, Francielle Liz Monteiro, Fabiana Caroline Zempulski Volpato, Julia Biz Willig, Otávio von Ameln Lovison, Alexandre Prehn Zavascki, Afonso Luís Barth, Andreza Francisco Martins

Abstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. COVID-19 mortality in Brazil, 2020-21: consequences of the pandemic inadequate management.Archives of public health = Archives belges de sante publique · 2022
    Article
  7. Article
  8. Review
  9. SARS-CoV-2 sublineages recovered from southern Brazilian cases during Omicron wave in 2023, early introduction of JN.1.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Priscila Lamb WinkLABRESIS-Laboratório de Pesquisa em Resistência Bacteriana, Hospital de Clínicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil.ORCID 0000-0002-8126-2365
Rafaela RamalhoBioinformatics Core, Hospital de Clínicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil.
Francielle Liz MonteiroLABRESIS-Laboratório de Pesquisa em Resistência Bacteriana, Hospital de Clínicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil.
Fabiana Caroline Zempulski VolpatoLABRESIS-Laboratório de Pesquisa em Resistência Bacteriana, Hospital de Clínicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil.
Julia Biz WilligLABRESIS-Laboratório de Pesquisa em Resistência Bacteriana, Hospital de Clínicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil.
Otávio von Ameln LovisonLABRESIS-Laboratório de Pesquisa em Resistência Bacteriana, Hospital de Clínicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil.
Alexandre Prehn ZavasckiLABRESIS-Laboratório de Pesquisa em Resistência Bacteriana, Hospital de Clínicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil.
Afonso Luís BarthLABRESIS-Laboratório de Pesquisa em Resistência Bacteriana, Hospital de Clínicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil.
Andreza Francisco MartinsLABRESIS-Laboratório de Pesquisa em Resistência Bacteriana, Hospital de Clínicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SARS-CoV-2 P.1 lineage emerged in Amazonas (AM), North Brazil and its evolution has been dynamically reported associated with increased transmissibility and/or immune evasion. Here, we evaluated the lineages circulating in 29 cities in Rio Grande do Sul (RS), Southern Brazil between March 2020 and May 2021 and investigated the genetic events associated with the emergence of the P.1. A total of 202 oro/nasopharyngeal SARS-CoV-2 specimens from patients during routine hospital care were submitted to whole-genome sequencing. Phylogenetic and Bayesian Evolutionary Analyses of the P.1 lineage were carried out to determine the relationship between sequences from RS and AM and dated their common ancestor and origin. One hundred six (53%) sequences were assigned as P.1 and most carried the 22 lineage-defining mutations. All the P.1 sequences included other important mutations, such as P314L and R203K/G204R, and revealed a high genetic diversity in the phylogenetic tree. The time-scaled inference suggests that the oldest P.1 sequences from different Brazilian states share a ancestor with those from AM, but the origin of some sequences from RS is unknown. Further, the common ancestor of sequences from RS is dated to mid-June/July 2020, earlier than those previously reported from AM. Our results demonstrate that there is a high degree of genetic diversity among P.1 sequences, which suggests a continuous evolution and community spread of the virus. Although the first P.1 outbreak was reported in AM, the lineage was associated with multiple introductory events and had already been circulating in Southern Brazil prior to November 2020.

Indexed as

Genome, ViralAdolescentAdultAgedAged, 80 and overBrazilChildChild, PreschoolCOVID-19FemaleGenomicsHumansInfantMaleMiddle AgedMutationSpike Glycoprotein, CoronavirusCOVID-19gammagenomic surveillanceP.1 lineageSARS-CoV-2

Identifiers

PMID35171035
PMCPMC8849062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.